North America HPV Testing And Pap Test Market is Expected to Increase from $1.73 Billion in 2016 to $2.41Billion in 2021 North America HPV Testing and Pap Test Market size was around USD 1.73 billion in 2016. It is expected to grow at a CAGR of 6.9% to reach USD 2.41 billion by 2021. It captures 50% of the global market. It is also the fastest growing market worldwide. The Papanicolaou test is a procedure of cervical screening utilized for detecting potentially pre-cancerous and cancerous processes in the cervix (opening of the womb or uterus). Irregular findings are usually followed up by more sensitive diagnostic tests, and based on the need interventions that prevent progression to cervical cancer are implemented. View Full Report: http://www.marketdataforecast.com/market-reports/north-america-hpvtesting-and-pap-test-market-3774/ Numerous factors for example, growing aging population, rising number of cervical cancer cases, growing awareness of cervical cancer screening programs, and government initiative and funding are driving the growth of the HPV testing market. Moreover, in order to carry out awareness campaigns, the government and major companies are funding the universities for developing enhanced technologies to facilitate effective screening, to mitigate the incidence of late-stage cervical cancer. Request for Sample Brochure: http://www.marketdataforecast.com/market-reports/northamerica-hpv-testing-and-pap-test-market-3774/request-sample In spite of that, changes in regulatory guidelines for cervical cancer screening and HPV vaccination are few factors hindering the growth of this market. Additionally, the uncertain reimbursement scenario is a major challenge inhibiting the growth of the HPV test and Pap test market. HPV testing market is segmented into two major segments on the basis of test type, namely, HPV testing. Follow-up HPV testing, HPV primary testing and co-testing are three sub-categories of HPV testing. The Pap test category is estimated to command the largest share of the HPV testing market in 2016. HPV testing category is projected to grow at the highest CAGR in the forecast period because of the growing incidences of cervical cancer, rising awareness of HPV screening, along with the introduction of HPV primary test. If we go by application, the North America HPV testing market is segmented into two major categories, namely, vaginal cancer screening and cervical cancer screening. Inquire Before Buying: http://www.marketdataforecast.com/market-reports/north-americahpv-testing-and-pap-test-market-3774/inquire The cervical cancer screening application category is estimated to command the largest share of the Pap test market in 2016. This large share is because of the rising incidences of cervical cancer and government initiatives to increase the awareness regarding the benefits of cervical cancer screening. Pap test market is categorized into three segments on basis of end users, namely, laboratories, hospitals, physicians’ offices and clinics. The laboratories end-user category is likely to command the largest share of the Pap test market in 2016. Moreover, the hospitals end-user category is estimated to grow at the highest CAGR in the future, because most of the diagnostic tests are carried out in-house in hospitals using advanced technologies in relatively shorter period of time. Market Segmentation                       Type 5.1.1 Introduction 5.1.2 HPV Testing 5.1.3 Follow-Up HPV Testing 5.1.4 Co-Testing 5.1.5 Primary HPV Testing 5.1.6 PAP Test 5.1.7 Y-o-Y Growth Analysis, By Type 5.1.8 Market Attractiveness Analysis, By 5.1.9 Market Share Analysis, By Type Application 5.2.1 Introduction 5.2.2 Cervical Cancer Screening 5.2.3 Vaginal Cancer Screening 5.2.5 Market Attractiveness Analysis, By 5.2.6 Market Share Analysis, By End User 5.3.1 Introduction 5.3.2 Laboratories 5.3.3 Hospitals 5.3.4 Physicians’ Offices and 5.3.5 Y-o-Y Growth Analysis, By End 5.3.6 Market Attractiveness Analysis, By End 5.3.7 Market Share Analysis, By End User On the basis of geography the North America market is segmented into US, Canada and Mexico. In 2016, North America commanded the market in terms of revenue because of the continual introduction of innovated technologies to improve patient care and diagnosis. Additionally, the high number of positive cases being detected, coupled with the increasing death toll (i.e., 2.6 in 1,00,000), has forced the government to carry out awareness programmes regarding the early diagnosis and treatment of cervical cancer, which is a major factor for the large market share. Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), Becton, Dickinson and Company (U.S.) are the key players operating in the HPV testing market. Scope of the Report:   Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of application, test type and end user along with market size forecasts and estimations to detect key areas of industry growth in detail        Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the north america market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decisionmaking personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions. Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/ View latest Press Releases of MDF @ http://www.marketdataforecast.com/pressreleases

North America HPV Testing and Pap Test Market size was around USD 1.73 billion in 2016. It is expected to grow at a CAGR of 6.9% to reach USD 2.41 billion by 2021.